Novel therapeutic and/or prophylactic agent for coronavirus infection (COVID-19)

The present invention provides: a novel therapeutic and/or prophylactic agent for coronavirus infection (COVID-19), which comprises 5-aminolevulinic acid (ALA), a derivative thereof, or a salt of the 5-aminolevulinic acid (ALA) or the derivative thereof; and a method for treating and/or prophylactic...

Full description

Saved in:
Bibliographic Details
Main Authors MORITA KOICHI, KAWATA SATOFUMI, SAKURAI YASUAKI, FUJINE KIYOTAKA, YASUDA JIRO, TANAKA TORU, TOMIOKA MOTOYASU, KITA KIYOSHI
Format Patent
LanguageChinese
English
Published 07.03.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides: a novel therapeutic and/or prophylactic agent for coronavirus infection (COVID-19), which comprises 5-aminolevulinic acid (ALA), a derivative thereof, or a salt of the 5-aminolevulinic acid (ALA) or the derivative thereof; and a method for treating and/or prophylactic for coronavirus infection (COVID-19), which uses the therapeutic and/or prophylactic agent. 本发明提供包含5-氨基乙酰丙酸(ALA)或其衍生物或者它们的盐的新型冠状病毒感染症(COVID-19)的治疗和/或预防剂、以及使用了该治疗和/或预防剂的新型冠状病毒感染症(COVID-19)的治疗和/或预防方法。
Bibliography:Application Number: CN202180029760